High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 14, Issue 7, 1994, Pages 1080-1083

  Falcon, Cristina R ^a   Cattaneo, Marco ^a,b   Panzeri, Daniela ^a   Martinelli, Ida ^a   Mannucci, Pier Mannuccio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Hemophilia and Thrombosis Center   (Italy)

Author keywords

Homocysteine; Pulmonary embolism; Venous thrombosis

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID DERIVATIVE; HOMOCYSTEINE;

ADULT; ARTICLE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FOLIC ACID BLOOD LEVEL; HOMOCYSTINURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; THROMBOEMBOLISM; VEIN THROMBOSIS; VITAMIN BLOOD LEVEL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; FEMALE; HOMOCYSTEINE; HUMAN; MALE; METHIONINE; MIDDLE AGE; PEDIGREE; PREVALENCE; PULMONARY EMBOLISM; THROMBOEMBOLISM;

EID: 0028335097     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.14.7.1080     Document Type: Article

References (11)

1. Mudd SH, Levy HL. Disorders of transsulfuration. In: Stanbury JB, Wyngarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The Metabolic Basis of Inherited Disease. New York, NY: McGraw-Hill Book Co; 1983:522-559.
2. Harker LA, Ross R, Slichter SJ, Scott CR. Homocysteine-induced arteriosclerosis. J Clin Invest. 1976;58:731-741.
3. DeGroot PG, Willems C, Boers GHJ, Gonsalves MD, Van Aken WG, Van Mourik JA. Endothelial cell dysfunction in homocystinuria. Eur J Clin Invest. 1983;13:405-410.
4. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest. 1986;77:1370-1376.
5. Rodgers GM, Kane WH. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest. 1986;77:1909-1916.
6. Rodgers GM, Conn MT. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood. 1990;75:895-901.
7. Lentz SR, Sadler JE. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest. 1991;88:1906-1914.
8. Hayashi T, Honda G, Suzuki K. An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells. Blood. 1992;79:2930-2936.
9. Harpel PC, Chang VT, Borth W. Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydril compound metabolism. Proc NatI Acad Sci USA. 1992;89:10193-10197.
10. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993;91:308-318.
11. Hajjar KA. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest. 1993;91:2873-2879.